Use Of Lysosomal Acid Lipase For Treating Lysosomal Acid Lipase Deficiency In Patients

Patent No. EP2613798 (titled "Use Of Lysosomal Acid Lipase For Treating Lysosomal Acid Lipase Deficiency In Patients") was filed by Synageva Biopharma on Sep 9, 2011. The application was issued on Jan 24, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FURO VENTURES B.V.Nov 10, 2015HENKEL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2613798

SYNAGEVA BIOPHARMA
Application Number
EP11758644A
Filing Date
Sep 9, 2011
Status
Patent Maintained As Amended
Dec 22, 2017
Publication Date
Jan 24, 2018